Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MEDIBIOTE 3: Analysis of Intestinal Microbiota as a Predictor of Response to Treatment of Spondyloarthritis With Biotherapy

NCT04899154 is registered in ClinicalTrials.gov with Hôpital Européen Marseille as lead sponsor.

NCT NCT04899154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04899154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MEDIBIOTE 3: Analysis of Intestinal Microbiota as a Predictor of Response to Treatment of Spondyloarthritis With Biotherapy
Lead sponsor
Hôpital Européen Marseille
Phase
Not applicable
Overall status
Recruiting
Start date
July 16, 2019
Completion date
May 15, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spondyloarthritis